Loading...

PE anti-mouse CD4 Antibody PE anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_GK1dot5_PE_021706
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 1_GK1dot5_PE_021706
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 2_GK15_PE_CD4_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100407 50 µg NOK207
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100408 200 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  3. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  4. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  5. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  6. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  7. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  8. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  9. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  10. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  11. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  12. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  13. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  14. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  15. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  16. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  17. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  18. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  19. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  20. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  21. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  22. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  23. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  24. Wang L, et al. 2022. Nutrients. 15: . PubMed
  25. Glaubitz J, et al. 2023. Gut. :. PubMed
  26. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  27. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  28. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  29. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  30. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  31. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  32. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  33. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  34. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  35. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  36. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  37. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  38. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  39. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  40. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  41. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  42. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  43. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  44. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  45. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  46. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  47. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  48. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  49. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  50. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  51. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  52. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  53. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  54. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  55. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  56. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  57. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  58. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  59. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  60. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  61. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  62. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  63. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  64. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  65. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  66. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  67. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  68. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  69. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  70. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  71. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  72. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  73. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  74. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  75. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  76. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  77. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  78. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  79. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  80. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  81. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  82. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  83. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  84. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  85. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  86. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  87. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  88. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  89. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  90. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  91. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  92. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  93. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  94. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  95. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  96. Lv F, et al. 2022. iScience. 25:103639. PubMed
  97. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  98. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  99. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  100. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  101. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  102. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  103. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  104. Yang H, et al. 2022. Nutrients. 14:. PubMed
  105. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  106. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  107. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  108. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  109. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  110. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  111. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  112. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  113. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  114. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  115. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  116. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  117. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  118. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  119. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  120. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  121. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  122. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  123. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  124. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  125. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  126. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  127. Du J, et al. 2018. AMB Express. 8:158. PubMed
  128. Cho K, et al. 2021. iScience. 24:103117. PubMed
  129. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  130. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  131. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  132. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  133. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  134. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  135. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  136. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  137. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  138. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  139. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  140. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  141. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  142. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  143. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  144. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  145. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  146. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  147. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  148. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  149. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  150. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  151. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  152. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  153. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  154. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  155. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  156. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  157. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  158. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  159. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  160. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  161. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  162. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  163. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  164. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  165. Chen S, et al. 2022. iScience. 25:105176. PubMed
  166. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  167. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  168. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  169. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  170. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  171. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  172. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  173. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  174. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  175. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  176. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  177. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  178. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  179. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  180. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  181. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  182. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  183. Li H, et al. 2022. iScience. 25:104481. PubMed
  184. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  185. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  186. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  187. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  188. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  189. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  190. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  191. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  192. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  193. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  194. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  195. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  196. Gawish R, et al. 2022. Elife. 11:. PubMed
  197. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  198. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  199. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  200. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  201. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  202. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  203. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  204. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  205. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  206. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  207. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  208. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  209. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  210. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  211. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  212. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  213. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  214. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  215. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  216. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  217. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  218. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  219. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  220. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  221. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  222. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  223. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  224. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  225. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  226. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  227. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  228. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  229. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  230. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  231. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  232. Wang L, et al. 2022. Nutrients. 15: . PubMed
  233. Glaubitz J, et al. 2023. Gut. :. PubMed
  234. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  235. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  236. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  237. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  238. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  239. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  240. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  241. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  242. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  243. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  244. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  245. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  246. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  247. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  248. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  249. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  250. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  251. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  252. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  253. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  254. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  255. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  256. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  257. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  258. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  259. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  260. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  261. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  262. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  263. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  264. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  265. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  266. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  267. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  268. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  269. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  270. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  271. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  272. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  273. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  274. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  275. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  276. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  277. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  278. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  279. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  280. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  281. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  282. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  283. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  284. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  285. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  286. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  287. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  288. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  289. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  290. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  291. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  292. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  293. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  294. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  295. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  296. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  297. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  298. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  299. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  300. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  301. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  302. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  303. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  304. Lv F, et al. 2022. iScience. 25:103639. PubMed
  305. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  306. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  307. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  308. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  309. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  310. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  311. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  312. Yang H, et al. 2022. Nutrients. 14:. PubMed
  313. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  314. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  315. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  316. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  317. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  318. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  319. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  320. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  321. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  322. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  323. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  324. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  325. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  326. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  327. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  328. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  329. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  330. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  331. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  332. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  333. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  334. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  335. Du J, et al. 2018. AMB Express. 8:158. PubMed
  336. Cho K, et al. 2021. iScience. 24:103117. PubMed
  337. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  338. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  339. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  340. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  341. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  342. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  343. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  344. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  345. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  346. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  347. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  348. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  349. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  350. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  351. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  352. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  353. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  354. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  355. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  356. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  357. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  358. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  359. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  360. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  361. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  362. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  363. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  364. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  365. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  366. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  367. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  368. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  369. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  370. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  371. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  372. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  373. Chen S, et al. 2022. iScience. 25:105176. PubMed
  374. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  375. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  376. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  377. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  378. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  379. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  380. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  381. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  382. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  383. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  384. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  385. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  386. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  387. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  388. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  389. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  390. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  391. Li H, et al. 2022. iScience. 25:104481. PubMed
  392. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  393. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  394. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  395. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  396. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  397. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  398. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  399. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  400. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  401. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  402. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  403. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  404. Gawish R, et al. 2022. Elife. 11:. PubMed
  405. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  406. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  407. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  408. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  409. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  410. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  411. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  412. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  413. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  414. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  415. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  416. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407)
AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_GK1dot5_PE_021706
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 1_GK1dot5_PE_021706
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 2_GK15_PE_CD4_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100407 50 µg NOK207
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100408 200 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  3. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  4. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  5. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  6. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  7. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  8. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  9. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  10. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  11. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  12. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  13. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  14. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  15. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  16. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  17. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  18. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  19. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  20. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  21. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  22. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  23. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  24. Wang L, et al. 2022. Nutrients. 15: . PubMed
  25. Glaubitz J, et al. 2023. Gut. :. PubMed
  26. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  27. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  28. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  29. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  30. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  31. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  32. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  33. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  34. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  35. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  36. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  37. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  38. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  39. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  40. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  41. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  42. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  43. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  44. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  45. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  46. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  47. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  48. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  49. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  50. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  51. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  52. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  53. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  54. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  55. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  56. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  57. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  58. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  59. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  60. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  61. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  62. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  63. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  64. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  65. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  66. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  67. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  68. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  69. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  70. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  71. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  72. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  73. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  74. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  75. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  76. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  77. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  78. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  79. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  80. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  81. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  82. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  83. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  84. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  85. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  86. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  87. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  88. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  89. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  90. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  91. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  92. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  93. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  94. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  95. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  96. Lv F, et al. 2022. iScience. 25:103639. PubMed
  97. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  98. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  99. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  100. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  101. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  102. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  103. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  104. Yang H, et al. 2022. Nutrients. 14:. PubMed
  105. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  106. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  107. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  108. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  109. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  110. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  111. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  112. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  113. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  114. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  115. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  116. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  117. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  118. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  119. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  120. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  121. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  122. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  123. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  124. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  125. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  126. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  127. Du J, et al. 2018. AMB Express. 8:158. PubMed
  128. Cho K, et al. 2021. iScience. 24:103117. PubMed
  129. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  130. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  131. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  132. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  133. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  134. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  135. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  136. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  137. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  138. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  139. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  140. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  141. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  142. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  143. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  144. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  145. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  146. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  147. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  148. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  149. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  150. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  151. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  152. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  153. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  154. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  155. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  156. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  157. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  158. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  159. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  160. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  161. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  162. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  163. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  164. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  165. Chen S, et al. 2022. iScience. 25:105176. PubMed
  166. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  167. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  168. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  169. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  170. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  171. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  172. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  173. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  174. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  175. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  176. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  177. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  178. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  179. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  180. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  181. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  182. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  183. Li H, et al. 2022. iScience. 25:104481. PubMed
  184. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  185. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  186. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  187. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  188. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  189. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  190. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  191. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  192. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  193. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  194. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  195. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  196. Gawish R, et al. 2022. Elife. 11:. PubMed
  197. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  198. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  199. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  200. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  201. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  202. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  203. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  204. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  205. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  206. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  207. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  208. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  209. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  210. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  211. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  212. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  213. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  214. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  215. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  216. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  217. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  218. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  219. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  220. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  221. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  222. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  223. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  224. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  225. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  226. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  227. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  228. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  229. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  230. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  231. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  232. Wang L, et al. 2022. Nutrients. 15: . PubMed
  233. Glaubitz J, et al. 2023. Gut. :. PubMed
  234. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  235. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  236. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  237. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  238. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  239. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  240. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  241. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  242. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  243. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  244. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  245. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  246. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  247. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  248. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  249. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  250. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  251. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  252. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  253. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  254. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  255. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  256. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  257. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  258. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  259. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  260. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  261. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  262. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  263. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  264. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  265. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  266. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  267. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  268. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  269. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  270. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  271. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  272. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  273. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  274. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  275. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  276. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  277. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  278. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  279. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  280. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  281. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  282. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  283. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  284. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  285. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  286. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  287. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  288. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  289. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  290. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  291. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  292. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  293. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  294. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  295. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  296. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  297. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  298. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  299. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  300. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  301. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  302. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  303. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  304. Lv F, et al. 2022. iScience. 25:103639. PubMed
  305. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  306. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  307. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  308. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  309. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  310. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  311. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  312. Yang H, et al. 2022. Nutrients. 14:. PubMed
  313. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  314. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  315. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  316. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  317. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  318. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  319. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  320. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  321. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  322. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  323. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  324. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  325. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  326. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  327. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  328. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  329. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  330. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  331. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  332. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  333. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  334. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  335. Du J, et al. 2018. AMB Express. 8:158. PubMed
  336. Cho K, et al. 2021. iScience. 24:103117. PubMed
  337. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  338. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  339. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  340. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  341. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  342. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  343. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  344. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  345. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  346. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  347. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  348. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  349. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  350. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  351. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  352. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  353. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  354. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  355. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  356. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  357. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  358. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  359. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  360. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  361. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  362. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  363. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  364. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  365. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  366. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  367. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  368. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  369. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  370. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  371. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  372. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  373. Chen S, et al. 2022. iScience. 25:105176. PubMed
  374. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  375. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  376. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  377. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  378. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  379. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  380. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  381. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  382. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  383. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  384. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  385. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  386. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  387. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  388. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  389. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  390. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  391. Li H, et al. 2022. iScience. 25:104481. PubMed
  392. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  393. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  394. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  395. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  396. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  397. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  398. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  399. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  400. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  401. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  402. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  403. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  404. Gawish R, et al. 2022. Elife. 11:. PubMed
  405. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  406. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  407. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  408. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  409. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  410. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  411. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  412. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  413. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  414. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  415. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  416. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407)
AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account